Effect of Maiqi-Jiangtang pill on the glycolipid level in type 2 diabetic ob/ob mice
10.3760/cma.j.issn.1673-4246.2019.01.010
- VernacularTitle:麦芪降糖丸对2型糖尿病ob/ob小鼠糖脂水平的影响
- Author:
Fang FANG
1
;
Xiaoye TIAN
;
Na?Wuken SHA
;
Xiaoli TANG
;
Jinying WU
;
Zhiwen QIAO
;
Xiaoxue CHEN
;
Xiaohong CHEN
;
Jianning SUN
Author Information
1. 北京中医药大学中药学院中药药理系 102488
- Keywords:
Diabetes mellitus,type 2;
Maiqi-Jiangtang pill;
Cholesterol;
Hypolipidemic drugs (TCD);
Hypoglycemic drugs (TCD);
Ob/ob mice
- From:
International Journal of Traditional Chinese Medicine
2019;41(1):39-43
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of Maiqi-Jiangtang pill on the glycolipid level in type 2 diabetic ob/ob mice.Methods The 8-week old male ob/ob mice were randomly divided into Maiqi-Jiangtang pill high- (8 g/kg), medium- (4 g/kg), low- (2 g/kg) dose groups. All the mice orally adiministered with the drugs once a day for 10 weeks. The same week age normal C57BL/6J control mice and ob/ob model group mice were orally administered with the equal volume solvent. The body weight per week were recorded. The fasting blood-glucose (FBG) was measured by glycemic instrument. The content of TG, TC, HDL-C, LDL-C in serum, and TG and TC content in liver were determined by biochemical method. The liver index was calculated.Results Compared with ob/ob model group, there was no significant change in body weight of mice administered with Maiqi-Jiangtang pill for 10 weeks. Compared with the model group, the low-, medium- dose Maiqi-Jiangtang pill could significantly decrease the FBG (7.43 ± 1.71 mmol/L,7.84 ± 1.09 mmol/L vs.8.95 ± 0.96mmol/L), the high- dose Maiqi-Jiangtang pill could significantly reduce the TG (0.93 ± 0.16 mmol/L vs.1.18 ± 0.26 mmol/L) and LDL-C (2.10 ± 0.51 mmol/L vs.2.56 ± 0.44 mmol/L) content in serum of ob/ob mice (P<0.05), increase the HDL-C/LDL-C ratio (2.40 ± 0.39vs.1.96 ± 0.24) in serum (P<0.01), decrease the liver weight (3.52 ± 0.26 gvs. 3.98 ± 0.35 g) and the liver index (0.063 ± 0.004vs. 0.071 ± 0.006) (P<0.05). Compared with the model group, the low dose Maiqi-Jiangtang pill could also significantly decrease the TG level (0.63 ± 0.25 mmol/gvs. 1.05 ± 0.67 mmol/g) in liver and significantly increase the HDL-C/LDL-C ratio (2.30 ± 0.44vs. 1.96 ± 0.24) in serum (P<0.05).Conclusions The Maiqi-Jiangtang pill can reduce lipid in serum and liver of ob/ob mice while it can decrease the blood glucose, which need to further study its mechanism.
